Interaction of a caffeine overdose with clinical doses of contraceptive ethinyl estradiol in a young woman

被引:0
|
作者
Adachi, Koichiro [1 ]
Murata, Maki [2 ]
Inada, Akiyoshi [3 ]
Morimoto, Takeyori [3 ]
Shimizu, Makiko [1 ]
Beppu, Satoru [2 ]
Yamazaki, Hiroshi [1 ]
机构
[1] Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, 3-2-1 Higashi tamagawa Gakuen, Machida, Tokyo 1948543, Japan
[2] NHO Kyoto Med Ctr, Emergency Med & Crit Care Dept, Fushimi ku, Kyoto, Japan
[3] NHO Kyoto Med Ctr, Pharmaceut Dept, Fushimi ku, Kyoto, Japan
来源
ACUTE MEDICINE & SURGERY | 2024年 / 11卷 / 01期
基金
日本学术振兴会;
关键词
caffeine; ethinyl estradiol; overdose; pharmacokinetics; ORAL-CONTRACEPTIVES; PLASMA-CONCENTRATIONS; ETHINYLESTRADIOL; INHIBITION; FLUOXETINE; GESTODENE; CYP2D6;
D O I
10.1002/ams2.985
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimThe overdose of caffeine, a cytochrome P450 1A2 probe, in young women has become a problem. The aim of this study was to evaluate possible drug interactions between intentionally overdosed caffeine (12 g) and oral contraceptive doses of ethinyl estradiol prescribed to a young woman in a suicide attempt.MethodsThe serum concentrations of caffeine in the patient and the time-dependent ethinyl estradiol inhibition of caffeine oxidation in vitro were evaluated.ResultsThe serum concentration of caffeine 4 h after overdose was 136 mu g/mL; from the data obtained between 4 and 28 h after overdose, the half-life was estimated to be 33 h, which is many times larger than the normal value. Prescribed ethinyl estradiol prolonged caffeine elimination in vivo and inhibited paraxanthine formation, as evidenced by the low serum concentrations. In human liver microsomes, ethinyl estradiol (50 nM) inhibited half of caffeine N3-demethylation. Pre-incubation of human liver microsomes with ethinyl estradiol resulted in a powerful time-dependent inhibitory effect on caffeine N3-demethylation in human liver microsomes.ConclusionThese results suggest that a prescription history of contraceptives at clinical doses may have a strong effect on the pharmacokinetics of overdosed caffeine in young women, resulting in dangerous drug interactions. Ethinyl estradiol prolonged caffeine elimination in vivo and inhibited P450 1A2-dependent caffeine main metabolite, paraxanthine formation, as evidenced by the low concentrations.image
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Effects of a triphasic combination oral contraceptive containing norgestimate/ethinyl estradiol on biochemical markers of bone metabolism in young women with osteopenia secondary to hypothalamic amenorrhea
    Grinspoon, SK
    Friedman, AJ
    Miller, KK
    Lippman, J
    Olson, WH
    Warren, MP
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (08): : 3651 - 3656
  • [32] Repeated exposure to physiologically effective doses of contraceptive hormones ethinyl estradiol or levonorgestrel do not alter the reinforcing effects of a brief visual stimulus in ovary-intact rats
    McNealy, Kathleen R.
    Oevermann, Matthew W.
    Knabel, MacKenzie L.
    Fitzwater, Anna
    Gipson, Cassandra D.
    Barrett, Scott T.
    Bevins, Rick A.
    HORMONES AND BEHAVIOR, 2024, 161
  • [33] Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome
    Kriplani, Alka
    Periyasamy, Anurekha Janaki
    Agarwal, Nutan
    Kulshrestha, Vidushi
    Kumar, Anand
    Ammini, Ariachery Chinnama
    CONTRACEPTION, 2010, 82 (02) : 139 - 146
  • [34] International clinical experience with a new low-dose, monophasic oral contraceptive containing levonorgestrel 100 μg and ethinyl estradiol 20 μg
    Boerrigter, PJ
    Ellman, H
    Dolker, M
    CLINICAL THERAPEUTICS, 1999, 21 (01) : 118 - 127
  • [35] Lack of Drug-Drug Interaction between Filgotinib, a JAK-1 Selective Inhibitor, and a Representative Hormonal Contraceptive Medication, Levonorgestrel/Ethinyl Estradiol
    Begley, Rebecca
    Anderson, Kacey
    Watkins, Timothy R.
    Shen, Jing
    Zheng, Hao
    Vass, Eugene
    Qin, Ann
    Kearney, Brian P.
    Xin, Yan
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [36] Increased plasma viscosity in young women with polycystic ovary syndrome using an oral contraceptive containing 35 μg ethinyl estradiol and 2 mg cyproterone acetate
    Markantes, George
    Saltamavros, Alexandros D.
    Vervita, Vasiliki
    Armeni, Anastasia K.
    Karela, Anastasia
    Adonakis, George
    Decavalas, George
    Georgopoulos, Neoklis A.
    GYNECOLOGICAL ENDOCRINOLOGY, 2011, 27 (12) : 971 - 977
  • [37] Ovarian activity in women taking an oral contraceptive containing 20 μg ethinyl estradiol and 150 μg desogestrel:: Effects of low estrogen doses during the hormone-free interval
    Killick, SR
    Fitzgerald, C
    Davis, A
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (01) : S18 - S24
  • [38] Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone® progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen
    Weisberg, E
    Brache, V
    Alvarez, F
    Massai, R
    Mishell, DR
    Apter, D
    Gale, J
    Sivin, I
    Tsong, YY
    Fraser, IS
    CONTRACEPTION, 2005, 72 (01) : 46 - 52
  • [39] A DRUG-DRUG INTERACTION STUDY TO EVALUATE THE EFFECTS OF STRONG CYP3A INHIBITION ON THE PHARMACOKINETICS OF SEGESTERONE ACETATE AND ETHINYL ESTRADIOL IN A CONTRACEPTIVE VAGINAL SYSTEM.
    Haddad, Lisa
    Plagianos, Marlena
    Sussman, Heather
    Kushner, Harvey
    Creasy, George W.
    Graham, Shelli
    Bernick, Brian
    Mirkin, Sebastian
    FERTILITY AND STERILITY, 2021, 116 (03) : E48 - E48
  • [40] Evaluation of Potential Drug-Drug Interaction Between Delayed-Release Dimethyl Fumarate and a Commonly Used Oral Contraceptive (Norgestimate/Ethinyl Estradiol) in Healthy Women
    Zhu, Bing
    Nestorov, Ivan
    Zhao, Guolin
    Meka, Venkata
    Leahy, Mark
    Kam, Jeanelle
    Sheikh, Sarah I.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (06): : 604 - 613